Integrated and specialist analytical, research and development in chemical science

Edinburgh Pharmaceutical Processes [“EPP”], was founded in 1992 by Dr Stephen Newlands, originally an industrial research chemist with BP and thereafter a pharmaceutical research and development chemist with a Glaxo subsidiary (Macfarlan Smith Ltd) in Edinburgh. Stephen founded EPP with his own capital, drawing on the foundations of his previous industrial experience coupled with a desire to create a sustainable contract research organisation (CRO) utilising the considerable local graduate scientific labour resource associated with the leading universities situated in Scotland’s capital, Edinburgh.

Stephen has been responsible for leading and directing the company from its creation.

EPP’s experience

Since 1992 we have been developing and strengthening our knowledge, experience and expertise. We now have:

• Experience with >280 Actives across Agrochemical, Pharmaceutical and Veterinary products
• 100s of Five Batch Analyses Conducted
• Synthesised metabolites or impurities of >180 different Actives
• Full 5-Batch Analysis on more than 110 different Actives